Stilla Technologies
Pre-clinicalStilla Technologies is taking multiplex digital PCR to a whole new level with a unique 7-color target detection capability
Founded
2016
Focus
DiagnosticsGenetics & Genomics
About
Stilla Technologies is taking multiplex digital PCR to a whole new level with a unique 7-color target detection capability
Funding History
2Total raised: $54M
Series B$34MKurma PartnersJun 15, 2021
Series A$20MIllumina VenturesOct 15, 2018
Company Info
TypePrivate
Founded2016
LocationParis, France
StagePre-clinical
Contact
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile